CHEK2 and pure red-cell aplasia: To evaluate the previously suggested contribution of CHEK2 variant c.349A>G to early-onset and/ or familial PrCa risk, we screened a series of 462 early-onset/familial PrCa cases and compared the frequency in cases with that previously obtained for 710 controls.